Age-related macular degeneration (AMD) is an eye disease that can blur the sharp, central vision you need for activities like reading and driving. "Age-related" means that it often happens in older people. "Macular" means it affects a part of your eye called the macula.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Age Related Macular Degeneration (AMD) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Lucentis
Eylea
Avastin
Other
Market Segment by Product Application
Hospitals
Clinics
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Age Related Macular Degeneration (AMD) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Age Related Macular Degeneration (AMD) market by identifying its various subsegments.
3.Focuses on the key global Age Related Macular Degeneration (AMD) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Age Related Macular Degeneration (AMD) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Age Related Macular Degeneration (AMD) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Age Related Macular Degeneration (AMD) Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Age Related Macular Degeneration (AMD) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Age Related Macular Degeneration (AMD) Segment by Type
2.1.1 Lucentis
2.1.2 Eylea
2.1.3 Avastin
2.1.4 Other
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Clinics
2.2.3 Other
2.3 Global Age Related Macular Degeneration (AMD) Market Comparison by Regions (2017-2027)
2.3.1 Global Age Related Macular Degeneration (AMD) Market Size (2017-2027)
2.3.2 North America Age Related Macular Degeneration (AMD) Status and Prospect (2017-2027)
2.3.3 Europe Age Related Macular Degeneration (AMD) Status and Prospect (2017-2027)
2.3.4 China Age Related Macular Degeneration (AMD) Status and Prospect (2017-2027)
2.3.5 Japan Age Related Macular Degeneration (AMD) Status and Prospect (2017-2027)
2.3.6 Southeast Asia Age Related Macular Degeneration (AMD) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Age Related Macular Degeneration (AMD) Industry Impact
2.5.1 Age Related Macular Degeneration (AMD) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Age Related Macular Degeneration (AMD) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Age Related Macular Degeneration (AMD) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Age Related Macular Degeneration (AMD) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Age Related Macular Degeneration (AMD) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Age Related Macular Degeneration (AMD) Manufacturer Market Share
3.5 Top 10 Age Related Macular Degeneration (AMD) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Age Related Macular Degeneration (AMD) Market
3.7 Key Manufacturers Age Related Macular Degeneration (AMD) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Age Related Macular Degeneration (AMD) Industry Key Manufacturers
4.1 Regeneron Pharmaceuticals
4.1.1 Compan Detail
4.1.2 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification
4.1.3 Regeneron Pharmaceuticals 134 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Regeneron Pharmaceuticals News
4.2 Bayer HealthCare
4.2.1 Compan Detail
4.2.2 Bayer HealthCare Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification
4.2.3 Bayer HealthCare Age Related Macular Degeneration (AMD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Regeneron Pharmaceuticals News
4.3 Novartis
4.3.1 Compan Detail
4.3.2 Novartis Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification
4.3.3 Novartis Age Related Macular Degeneration (AMD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Novartis News
4.4 Roche
4.4.1 Compan Detail
4.4.2 Roche Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification
4.4.3 Roche Age Related Macular Degeneration (AMD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Roche News
4.5 Kanghong Pharma
4.5.1 Compan Detail
4.5.2 Roche Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification
4.5.3 Kanghong Pharma Age Related Macular Degeneration (AMD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Kanghong Pharma News
5 Global Age Related Macular Degeneration (AMD) Market Segment by Big Type
5.1 Global Age Related Macular Degeneration (AMD) Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Age Related Macular Degeneration (AMD) Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Age Related Macular Degeneration (AMD) Revenue and Market Share by Big Type (2017-2022)
5.2 Lucentis Sales Growth Rate and Price
5.2.1 Global Lucentis Sales Growth Rate (2017-2022)
5.2.2 Global Lucentis Price (2017-2022)
5.3 Eylea Sales Growth Rate and Price
5.3.1 Global Eylea Sales Growth Rate (2017-2022)
5.3.2 Global Eylea Price (2017-2022)
5.4 Avastin Sales Growth Rate and Price
5.4.1 Global Avastin Sales Growth Rate (2017-2022)
5.4.2 Global Avastin Price (2017-2022)
5.5 Other Sales Growth Rate and Price
5.5.1 Global Other Sales Growth Rate (2017-2022)
5.5.2 Global Other Price (2017-2022)
6 Global Age Related Macular Degeneration (AMD) Market Segment by Big Application
6.1 Global Age Related Macular Degeneration (AMD) Sales Market Share by Big Application (2017-2022)
6.2 Hospitals Sales Growth Rate (2017-2022)
6.3 Clinics Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Age Related Macular Degeneration (AMD) Forecast
7.1 Global Age Related Macular Degeneration (AMD) Revenue, Sales and Growth Rate (2022-2027)
7.2 Age Related Macular Degeneration (AMD) Market Forecast by Regions (2022-2027)
7.2.1 North America Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
7.2.2 Europe Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
7.2.3 China Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
7.2.4 Japan Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
7.2.5 Southeast Asia Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
7.2.6 Other Regions Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
7.3 Age Related Macular Degeneration (AMD) Market Forecast by Type (2022-2027)
7.3.1 Global Age Related Macular Degeneration (AMD) Sales Forecast by Type (2022-2027)
7.3.2 Global Age Related Macular Degeneration (AMD) Market Share Forecast by Type (2022-2027)
7.4 Age Related Macular Degeneration (AMD) Market Forecast by Application (2022-2027)
7.4.1 Global Age Related Macular Degeneration (AMD) Sales Forecast by Application (2022-2027)
7.4.2 Global Age Related Macular Degeneration (AMD) Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Age Related Macular Degeneration (AMD) Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Age Related Macular Degeneration (AMD) Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Age Related Macular Degeneration (AMD)
Figure Market Concentration Ratio and Market Maturity Analysis of Age Related Macular Degeneration (AMD)
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Age Related Macular Degeneration (AMD) Market Size by Big Type
Figure Global Market Share of Age Related Macular Degeneration (AMD) by Big Type in 2021
Figure Lucentis Picture (2017-2022)
Figure Eylea Picture (2017-2022)
Figure Avastin Picture (2017-2022)
Global Age Related Macular Degeneration (AMD) Market Size by Big Application
Table Global Age Related Macular Degeneration (AMD) Market Size by Application
Figure Global Age Related Macular Degeneration (AMD) Market Share by Big Application in 2021
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Table Global Age Related Macular Degeneration (AMD) Comparison by Regions (M USD) (2017-2027)
Figure Global Age Related Macular Degeneration (AMD) Market Size (Million US$) (2017-2027)
Figure North America Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate (2017-2027)
Figure China Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Age Related Macular Degeneration (AMD) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Age Related Macular Degeneration (AMD) Sales by Manufacturer (2017-2022)
Figure Global Age Related Macular Degeneration (AMD) Sales Market Share by Manufacturer in 2021
Table Global Age Related Macular Degeneration (AMD) Revenue by Manufacturer (2017-2022)
Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share by Manufacturer in 2021
Table Global Age Related Macular Degeneration (AMD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Age Related Macular Degeneration (AMD) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Age Related Macular Degeneration (AMD) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Age Related Macular Degeneration (AMD) Market
Table Key Manufacturers Age Related Macular Degeneration (AMD) Product Type
Table Mergers & Acquisitions Planning
Table Regeneron Pharmaceuticals Company Profile
Table Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification of Regeneron Pharmaceuticals
Table Age Related Macular Degeneration (AMD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Bayer HealthCare Company Profile
Table Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification of Bayer HealthCare
Table Age Related Macular Degeneration (AMD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer HealthCare Recent Development
Table Novartis Company Profile
Table Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification of Novartis
Table Age Related Macular Degeneration (AMD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Roche Company Profile
Table Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification of Roche
Table Age Related Macular Degeneration (AMD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Roche Main Business
Table Roche Recent Development
Table Kanghong Pharma Company Profile
Table Age Related Macular Degeneration (AMD) Product Introduction, Application and Specification of Kanghong Pharma
Table Age Related Macular Degeneration (AMD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kanghong Pharma Main Business
Table Kanghong Pharma Recent Development
Figure Global Age Related Macular Degeneration (AMD) Sales and Growth Rate (2017-2022)
Figure Global Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2017-2022)
Table Global Age Related Macular Degeneration (AMD) Sales by Regions (2017-2022)
Figure Global Age Related Macular Degeneration (AMD) Sales Market Share by Regions in 2021
Table Global Age Related Macular Degeneration (AMD) Revenue by Regions (2017-2022)
Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share by Regions in 2021
Figure North America Age Related Macular Degeneration (AMD) Sales and Growth Rate (2017-2022)
Figure Europe Age Related Macular Degeneration (AMD) Sales and Growth Rate (2017-2022)
Figure China Age Related Macular Degeneration (AMD) Sales and Growth Rate (2017-2022)
Figure Japan Age Related Macular Degeneration (AMD) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Age Related Macular Degeneration (AMD) Sales and Growth Rate (2017-2022)
Figure Other Regions Age Related Macular Degeneration (AMD) Sales and Growth Rate (2017-2022)
Table Global Age Related Macular Degeneration (AMD) Sales by Big Type (2017-2022)
Table Global Age Related Macular Degeneration (AMD) Sales Market Share by Big Type (2017-2022)
Figure Global Age Related Macular Degeneration (AMD) Sales Market Share by Big Type in 2019
Table Global Age Related Macular Degeneration (AMD) Revenue by Big Type (2017-2022)
Table Global Age Related Macular Degeneration (AMD) Revenue Market Share by Big Type (2017-2022)
Table Global Age Related Macular Degeneration (AMD) Revenue Market Share by Big Type in 2019
Figure Global Lucentis Sales Growth Rate (2017-2022)
Figure Global Lucentis Price (2017-2022)
Figure Global Eylea Sales Growth Rate (2017-2022)
Figure Global Eylea Price (2017-2022)
Figure Global Avastin Sales Growth Rate (2017-2022)
Figure Global Avastin Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Table Global Age Related Macular Degeneration (AMD) Sales by Big Application (2017-2022)
Table Global Age Related Macular Degeneration (AMD) Sales Market Share by Big Application (2017-2022)
Figure Global Age Related Macular Degeneration (AMD) Sales Market Share by Big Application in 2019
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Clinics Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Age Related Macular Degeneration (AMD) Sales and Growth Rate (2022-2027)
Figure Global Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2022-2027)
Table Global Age Related Macular Degeneration (AMD) Sales Forecast by Regions (2022-2027)
Table Global Age Related Macular Degeneration (AMD) Market Share Forecast by Regions (2022-2027)
Figure North America Sales Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
Figure Europe Sales Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
Figure China Sales Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
Figure Japan Sales Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
Figure Southeast Asia Sales Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
Figure Other Regions Sales Age Related Macular Degeneration (AMD) Market Forecast (2022-2027)
Table Global Age Related Macular Degeneration (AMD) Sales Forecast by Type (2022-2027)
Table Global Age Related Macular Degeneration (AMD) Market Share Forecast by Type (2022-2027)
Table Global Age Related Macular Degeneration (AMD) Sales Forecast by Application (2022-2027)
Table Global Age Related Macular Degeneration (AMD) Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration (AMD)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Age Related Macular Degeneration (AMD) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Age Related Macular Degeneration (AMD) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Age Related Macular Degeneration (AMD) Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Age Related Macular Degeneration (AMD) Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Age Related Macular Degeneration (AMD) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)